Table 1 Patient demographics and characteristics (safety population) and lung function at baseline (intent-to-treat [ITT] population)

Patient demographics (safety population)

N

Age, years

(range)

Female sex, n (%)

White race, n (%)

Patient characteristics (safety population)

Duration of asthma, years

≥ 1 exacerbation in prior 12 months, n (%)

Lung function parameters (ITT population)

N

Percent reversibility FEV₁ at screening,%

Pre-dose FEV₁ at baseline, L

Percent predicted FEV₁ at baseline,%